Published in Diabetes Week, April 29th, 2002
NovoMix 30 is an insulin analogue combining 30% rapid-acting insulin aspart, and 70% intermediate-acting insulin aspart.
NovoMix 30 will be available in FlexPen , a new prefilled insulin pen designed to be simpler, easier, and more discreet to use than other prefilled pens.
"Our goal for the development of NovoMix 30 FlexPen was to find the best way to help people with diabetes start on insulin therapy simply and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.